NEW YORK, Feb. 11, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in GSK plc (“GSK” or the “Company”) (NYSE: GSK) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of GSK investors who were adversely affected by alleged…
Month: February 2025
NEW YORK, Feb. 11, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in MGP Ingredients, Inc. (“MGP Ingredients, Inc.” or the “Company”) (NASDAQ: MGPI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of MGP Ingredients, Inc….
NEW YORK, Feb. 11, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Joint Stock Company Kaspi.kz (“Joint Stock Company Kaspi.kz” or the “Company”) (NASDAQ: KSPI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Joint…
NEW YORK, Feb. 11, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQ: AZN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of AstraZeneca investors who were…
NEW YORK, Feb. 11, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Capri Holdings Limited (“Capri Holdings” or the “Company”) (NYSE: CPRI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Capri Holdings investors who…
NEW YORK, Feb. 11, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Caribou Biosciences, Inc. (“Caribou Biosciences, Inc.” or the “Company”) (NASDAQ: CRBU) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Caribou…
NEW YORK, Feb. 11, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Regeneron investors…
NEW YORK, Feb. 11, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Novo Nordisk A/S (“Novo” or the “Company”) (NYSE: NVO) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Novo investors who were adversely affected by…
NEW YORK, Feb. 11, 2025 /PRNewswire/ — Report with the AI impact on market trends – The logistics market in Europe and it is set to grow by USD 48.4 billion from 2025 to 2029. However, the growth momentum will progressing at a CAGR of 3.4% during the forecast period, according to…
BUCAREST, Rumanía, 11 de febrero de 2025 /PRNewswire/ — Morphosis Capital Partners BV, un fondo de capital de crecimiento, anuncia el lanzamiento de Morphosis Capital Fund II, su segundo fondo de inversión, con un capital comprometido de más de 100 millones de euros. Esta cifra duplica…